Substance / Medication

Riboflavin

Overview

Active Ingredient

riboflavin

RxNorm CUI

9346

Indications

Dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.

Labeler: Hillestad Pharmaceuticals USAUpdated: 2027-01-27T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Ariboflavinosis

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Riboflavin

LOINC 109509-0

name_match

Research Evidence

Published studies and systematic reviews

Sort:

Effects of deficiency or supplementation of riboflavin on energy metabolism: a systematic review with preclinical studies.

da Silva-Araújo Eulália Rebeca, Toscano Ana Elisa, Silva Paula Brielle Pontes et al. · Nutr Rev · 2025

PMID: 38719205Meta-Analysis

Riboflavin supplements for blood pressure lowering in adults.

Bradbury Kathryn E, Coffey Sean, Earle Nikki et al. · Cochrane Database Syst Rev · 2025

PMID: 41123035Meta-AnalysisFull text (PMC)

Effects of riboflavin in the treatment of brain damage caused by oxygen deprivation: an integrative systematic review.

Silva-Araújo Eulália Rebeca da, Manhães-de-Castro Raul, Pontes Paula Brielle et al. · Nutr Neurosci · 2024

PMID: 38095869Meta-Analysis

Exploring trajectories in dietary adequacy of the B vitamins folate, riboflavin, vitamins Band B, with advancing older age: a systematic review.

Gillies N, Cameron-Smith D, Pundir S et al. · Br J Nutr · 2021

PMID: 33118888Meta-Analysis

Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM).

Powers Hilary J, Hill Marilyn H, Mushtaq Sohail et al. · Am J Clin Nutr · 2011

PMID: 21525198RCT

Study Protocol: randomised controlled trial to investigate the functional significance of marginal riboflavin status in young women in the UK (RIBOFEM).

Hill Marilyn H E, Mushtaq Sohail, Williams Elizabeth A et al. · BMC Public Health · 2009

PMID: 19323801RCTFull text (PMC)

Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren.

Vinodkumar Malavika, Rajagopalan Srinivasa · Food Nutr Bull · 2009

PMID: 19927606RCT

Riboflavin status in acute ischaemic stroke.

Gariballa S, Ullegaddi R · Eur J Clin Nutr · 2007

PMID: 17299470RCT

Supplementation with iron and riboflavin enhances dark adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind Nepali women.

Graham Joanne M, Haskell Marjorie J, Pandey Pooja et al. · Am J Clin Nutr · 2007

PMID: 17490976RCT

Riboflavin Deficiency and Apoptosis: A Review.

Zhang Bo, Hou Shuisheng, Tang Jing · J Nutr · 2025

PMID: 39510506Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Riboflavin (substance)
SNOMED CT: 13235001
UMLS CUI: C0035527
RxNorm CUI: 9346
Labeler: Hillestad Pharmaceuticals USA

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.